Zynex (ZYXI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual shareholder meeting scheduled for May 15, 2025, at the company headquarters in Englewood, CO.
Proxy materials are available online to reduce costs and environmental impact.
Shareholders can vote online, by phone, mail, or in person at the meeting.
Voting matters and shareholder proposals
Election of four directors: Thomas Sandgaard, Barry D Michaels, Michael Cress, and Joshua R Disbrow.
Ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year ending December 31, 2025.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR the auditor ratification proposal.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Zynex
- Q2 revenue up 11% to $49.9M, but net income fell as expenses and product mix shifted.ZYXI
Q2 20242 Feb 2026 - Sales force productivity and new device launches drive growth, with major FDA milestones ahead.ZYXI
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Q3 2024 revenue flat at $50M, 13% order growth, 2024 revenue outlook raised to $200M.ZYXI
Q3 202418 Jan 2026 - Tricare payment suspension led to Q4 loss; cost cuts and new products aim for 2025 recovery.ZYXI
Q4 202425 Dec 2025 - $100 million shelf registration targets growth in pain management and patient monitoring devices.ZYXI
Registration Filing16 Dec 2025 - Director elections, auditor ratification, and strong governance are key meeting topics.ZYXI
Proxy Filing1 Dec 2025 - Q1 2025 revenue fell 43% to $26.6M, with cost cuts and new product plans amid TRICARE suspension.ZYXI
Q1 202528 Nov 2025 - Severe revenue decline, $42.9M net loss, and liquidity crisis amid restructuring efforts.ZYXI
Q3 202519 Nov 2025 - Q2 2025 revenue fell 55% and net loss reached $20M amid Tricare suspension and restructuring.ZYXI
Q2 202516 Nov 2025